BOTHELL, Wash.--(BUSINESS WIRE)--Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that Ryo Kubota, M.D., Ph.D., Acucela’s chairman, president and chief executive officer, will present a company update at the Rodman & Renshaw 11th Annual Healthcare Conference. The presentation is scheduled for 4:55 p.m. EDT on Wednesday, September 9, 2009 at the New York Palace Hotel in New York City.
